Portfolio Finder

NAVAN, Inc. (NAVAN) is an early-stage private biotechnology company developing a novel, proprietary NanoStraw platform to enable the next generation of cell and gene therapies. A non-viral physical delivery technology, NanoStraws provide direct access to the cytosol of a cell and enable the delivery of Any Cargo into Any Cell in a gentle, non-perturbative manner. High cell viability, the ability to have multiple deliveries of different cargos into a cell, and no cargo size limitations are hallmarks of the platform. Cell transformation via NanoStraws will drastically reduce the complexity, cost and technical challenges involved in cell therapy manufacturing, allowing NAVAN to actively pursue the development of innovative therapies in a broad range of indications with its strategic collaborators and partners.

Nebula Biocides GmbH was founded in 2019 as a spin-off from the Leibniz Institute for Plasma Science and Technology (INP) by the scientists Dr. Jörn Winter, Dr. Ansgar Schmidt-Bleker and the director of INP Prof. Dr. Klaus-Dieter Weltmann. With the aim of providing comprehensive protection against infectious pathogens, the company develops application-oriented disinfection solutions that reliably kill not only bacteria and viruses but also persistent bacterial spores.

neotiv is a spin-off of the Otto von Guericke University in the German city of Magdeburg in close collaboration with the Magdeburg site of the German Centre for Neurodegenerative Diseases (DZNE). neotiv incorporates the latest scientific findings from the fields of neuroscience and dementia research into mobile software that can be used on smartphones and tablets. Our work focuses on the development of a digital assistant that can monitor and aid users' memories and provide support for patients with dementia. neotiv is also designed to improve the early detection of Alzheimer's dementia and to facilitate efficacy monitoring for new therapies as they become available in the future. Biologically and anatomically valid and user-oriented measurements of specific memory functions, which can be carried out on a regular basis, form the core of the development of neotiv. The measurements focus on regions of the brain that are affected in the early stages of Alzheimer's disease. The vision behind neotiv is to (i) help reducing risk factors for cognitive decline by making lifestyle change simple and cognitive health measurable and (ii) to enable the innovative early detection of cognitive difficulties and dementia risk.

Deep learning and AI have revolutionized how images, sounds and natural language are processed. However, software for Computer-Aided Design (CAD) for the development of technical products is still using traditional techniques. Neural Concept Shape is the first deep learning software solution dedicated to Computer Assisted Engineering and Design. The cloud-based simulation software allows clients to speed up development cycles, enhance product performance and reduce computational costs.

Neural Concept was founded in the spring of 2018. The start-up is a spin-off from EPFL’s computer vision laboratory where the founding team developed the fundamental technology. The company has also been supported by the Venture Kick support scheme.

Next Kraftwerke links microgeneration plants and creates a virtual power plant. Pooling such plants makes unused resources available to the electricity market

We connect the world in Munich. In 2007 we stirred up the blue and white sky above Bavaria with an invisible cloud. A very special cloud still revolutionizing worldwide business telephony to this day. We’re NFON AG, a worldwide leading provider of high-end telephone systems from the cloud. More than 150 creative, skilled and passionate employees in Munich, Mainz and over ten countries (eight other branches) throughout Europe ensure you stay talking. Whenever you want. Wherever you want. With whomever you want.

We take the telephone system out of the office – and into the NFON high performance computer centers. With an encrypted internet connection you can now access your phone system from around the world by phone, computer or smartphone, always connected to the classic telephone network.

Regardless of location, flexible, free and at a low price. And thanks to free for life cloud updates you’re always up to date. We make everyday business life a little simpler. And your communications more secure.

Whether you’re a local small business or international major enterprises: Our cloud telephone system can serve businesses of 2 to 249,000 employees. That’s what we like to do. That’s what we do best. With more than 10,000 satisfied customers. We’ve also received a certificate and seal from TÜV Saarland. And frequent praise from the media. ChannelPartner elected us the best known provider of cloud telephony service, the Handelsblatt writes about “calls from cloud 9”. And we keep doing what we know best: we connect what belongs together.

Nia Health is a spin-off of the Charité Universitätsmedizin Berlin. The start-up develops a clinical diagnosis and therapy system for the continuous digital support of patients with chronic skin conditions. With its platform, Nia Health addresses an often highly underserved patient population and generates treatment-relevant real world evidence. With its innovative machine vision approach, Nia Health enables accurate documentation of disease and therapy progression and thus optimised treatment. The company works closely with German patient associations and leading clinicians and has already won reputable customers from
the insurance and pharmaceutical industries. Amongst others, the Berlin-based company has developed the award-winning apps in the fields of atopic dermatitis (Nia) and psoriasis (Sorea), which were the first digital medical products of their kind to be approved worldwide. The digital medical solutions from Nia Health provide daily support for thousands of patients and their families.

node.energy offers a software-as-a-service for the commercial optimization of local energy concepts – so-called microgrids. This allows industrial and commercial companies with on-site power generation to reduce both, their energy costs and CO2 footprint. The company is supported by the Climate-KIC Accelerator of the European Union and is the winner of the Startup Award 2017 of the auditing company EY. node.energy was founded in 2016 by Matthias Karger and Lars Rinn and is based in Frankfurt am Main.

Nordantech develops an intelligent project management software for enterprise transformations: Falcon. Falcon makes it possible to coordinate and manage complex projects in addition to the daily business in terms of milestones and financial effects through time-saving and clear-cut features. Falcon learns independently. Hence delays are detected early. Since Falcon can be used simultaneously in any number of departments and companies, especially management consultancies, holding companies and private equity firms enjoy Falcon.

In order to successfully treat the infected patient, you have to recognize and diagnose most reliably the infecting microbe.
Noscendo changes the way infection causative microbes are identified. Through a paradigm shift we introduce by using proprietary algorithms and software harnessing next generation sequencing, we identify pathogens from cell free nucleic acids in patient samples and thereby aid intensive care clinicians in their daily task to find the right decisions, enabling a targeted and successful treatment in an actionable timeframe.

Notch is a modular workspace for buyer-seller collaboration, designed to simplify b2b sales from the first demo to customers’ success by bringing all elements of the sales process into one buyer-facing workspace. Notch was founded in 2021 by Viktor Kessler, Tim Dethlefsen, Devin Lemcke and Alex Sandau. Notch is a remote-first company, with most team members working from Hamburg or Berlin and others working in Italy, Hungary among other locations.

NovaPump GmbH is developing and realising a leading solution for a novel right ventricular assist device (RVAD) with clear USPs (the only percutaneous device with pulsatile support).
NovaPump’s catheter-based heart pump PERKAT™ can be implanted within minutes in acute situations involving acute right heart failure, cardiogenic shock or acute right heart insufficiency and offers highly efficient pulsatile heart support in combination with the existing IABP (Intra-Aortic Balloon Pump) technology as a drive.
A perspective application of PERKAT™ as a bi-ventricular assist device (bi-VAD) is also planned for the near future.

Novum offers through AI and a hardware module exact battery monitoring that enables 15% more capacity usage and 20% longer lifetime. The on-site instant battery characterisation enables multiple second-life use cases for batteries with a strong sustainability impact and increased safety against fire or explosions.

Numaferm developed a platform technology for fast, scalable and cost-efficient production of peptides and proteins, with a focus on pepteins (PEPTides & protEINS) in the range of 30-500 amino acids. They serve customers from pharma, biotech, agriculture, and cosmetics offering peptides and proteins at highest qualities, within weeks, in a sustainable way. In this context partnership deals with global CDMO PolyPeptide and the world’s leading animal health company Zoetis were closed.
Founded in 2017 as a spin-out of Düsseldorf University, Numaferm has grown to over 20 staff.

Nuuron was founded by Fabian Queisner and Dr. Markus Müschenich. The scientific director is Priv.-Doz. Dr. Julian Keil. The Nuuron team consists of experts in the fields of neuroscience, medicine, neuroinformatics, machine learning and public health.

NYRIS provides a state-of-the-art image and object recognition engine using latest Artificial Intelligence frameworks. The unique concept delivers very accurate results for 1D (codes), 2D (print2web) and 3D (real world products) typically below one second. The solution is available „as-a-service“ for both retail and industry customers.

O11 biomedical, a visionary medical technology start-up that emerged as part of BioTex at RWTH Aachen University/ University Hospital Aachen 2022, aims to improve survival rates and quality of life for patients struggling with severe respiratory distress. O11 has developed a disruptive therapy that allows patients to "breathe out" carbon dioxide via the intestines, freeing them from hours of agonizing ventilation therapy: RESPILIQ™. With currently 6 employees and its own production and development facility in Aachen, O11 is ideally positioned for the future.

oculai is a ConTech start-up that uses cameras and artificial intelligence to automatically monitor construction processes and progress. Founders Constantin Kauffmann (CEO), Tim Sippl (CTO) and Yannik Mack (CFO/ COO) met while studying at Friedrich-Alexander-Universität Erlangen-Nürnberg. The idea to found a start-up came from research into using cameras to monitor manual industrial processes. The start-up was formed as part of several founder programmes, such as the Digital Tech Academy, UnternehmerTUM and the Zollhof incubator, and subsequently received funding via the EXIST founder grant. oculai was then officially established in July 2021. Today, the company is based in Munich and employs around 20 members of staff. oculai’s product is an AI-based software solution that uses camera data to detect and automatically document outdoor construction processes. A web app provides users with access to a range of functions including automated target/actual schedules, the automatic drafting of daily construction reports, process KPIs and routes taken by workers. In doing so, it helps enhance transparency and productivity as part of construction projects while also making planning easier. Based on automated documentation and collected data, there is a potential cost savings of 7% for the total shell construction volume, as well as a time savings of 15% for site management teams.

OMEICOS Therapeutics develops a novel, first-in-class, small molecule drug addressing a new Mode of Action for the treatment and prevention of atrial fibrillation.

oncgnostics develops - based on proprietary epigenetic biomarkers - highly reliable molecular in-vitro diagnostic (IVD) tests for screening, follow-up care and therapeutic decisions in oncology.

ondeso develops software specifically in the fields industry 4.0 and digitalisation. No matter whether the client is a production company or a machine manufacturer, a medium sized business or a corporate group – ondeso supports them specifically in the field of IT operating management and security in production. The successfully launched products are suited for all industries and applicable across the entire range of production systems and procedures. Whether management systems, HMIs or controls – ondeso manages the lifecycle of industry PCs and offers custom fitted products on the highest technological and conceptual level - 100% made in Germany

OrbEx is an innovative space access company.

PAUL SECRET Outfittery takes the pain out of shopping for men by providing the first personal shopping service for customers, who want to be dressed well, but hate shopping.

Behind pagent.ai is aihumin GmbH, founded a year ago in Bonn, which pursues the development of application-oriented AI solutions in the field of communication. The team, with employees from five different countries, works with companies throughout Europe.

PANDA is a spin-off of the Helmut Schmidt University/University of the German Armed Forces in Hamburg with focus on Industrial AI. Founded in July 2018, the start-up has set itself the goal of securing the competitiveness of German engineering industry. With PANDA | DRIFT, PANDA offers an AI system for minimizing performance deficits in industrial production. The basis for this is a self-developed Machine Learning Framework, which has been optimized for industrial use by a combination of hardware and software. This enables the automatic identification of causes for production problems and the setting of optimal production parameters. The data-driven approach using artificial intelligence, enables automated process optimization and monitoring for the industry which is just right for the current era.

Pantherna Therapeutics is a privately-held biopharmaceutical company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on advanced nanoparticles for the delivery and expression of therapeutic mRNA drugs in the endothelium. Pantherna is based in Hennigsdorf (Brandenburg) close to Berlin, Germany.

payever was founded to make commerce easier for businesses of all types and sizes. The company provides a modular SaaS solution to sell everywhere and accept all payments.

PEPperPRINT produces customized ultra-high density peptide microarrays and uses individualized peptide libraries for drug development, antibody characterization, and protein biomarker discovery.

PerformaNat GmbH was founded in 2015 as a spin-off of the veterinary medicine department of the Freie Universität Berlin. The first product – an animal-feed additive for use with dairy cows – was developed with the help of the EXIST Transfer of Research Grant Program of the German Federal Ministry for Economic Affairs and Energy, and it has already been successfully out-licenced. Further products are being developed.

Phialogics is an innovative start-up in the field of autoimmune diseases. Founded in 2021 by a team of widely recognized experts in protein engineering and immunology, the company based in Basel (CH) and Heidelberg (GER) is committed to making a decisive contribution to the autoimmune disease space. The founding team is backed by strong Scientific Advisory and Supervisory Boards, which puts the company in a good position to move fast on the lead candidate and develop novel biologics.